FDA Approves Cannabidiol for Use in Epilepsy
Node Smith, ND On April 19, 2018, an advisory panel from the Federal Food and Drug Administration (FDA) recommended a new drug to be approved for the treatment of epilepsy.1 The drug, Epidiolex, produced by GW Pharmaceuticals in Britain, is a pure oral solution of cannabidiol, one of the primary endocannabinoids found in the herb […]